CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 8,000 shares at $5.74 ($45,920)
- 4 Option exercise President and CEO acquired 28,015 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,000 shares at $11.25 ($33,750)
- 4 Open-market sale Chief Operating Officer sold 13,500 shares at $14.01 ($189,135)
- 4 Open-market sale Chief Financial Officer sold 4,668 shares at $13.13 ($61,291)
- 4 Open-market sale Chief Financial Officer sold 2,158 shares at $12.96 ($27,968)
- 4 Open-market sale President and CEO sold 12,564 shares at $13.70 ($172,127)
- 4 Option exercise President and CEO acquired 10,000 shares (option exercise)
Page 8 of 11 · 212 filings